Market Research Report
Global Clinical Diagnostics Market, By Type of Test (Lipid Panel, Metabolic Panel, Infectious Disease Testing, Others), Product (Instruments, Reagents, Assays and Kits, Software), Application, Region, Competition, Forecast & Opportunities, 2025
|Published by||TechSci Research||Product code||932043|
|Published||Content info||119 Pages
Delivery time: Inquiry
|Global Clinical Diagnostics Market, By Type of Test (Lipid Panel, Metabolic Panel, Infectious Disease Testing, Others), Product (Instruments, Reagents, Assays and Kits, Software), Application, Region, Competition, Forecast & Opportunities, 2025|
|Published: April 1, 2020||Content info: 119 Pages||
Clinical diagnostics includes medical tests that are performed in a pathology or a diagnostic center or hospital or any other medical facility to diagnose or detect any disease or any other medical conditions. These tests help in early detection of a disease and identify the associated risk factors thereby creating opportunities for prevention and treatment. Global clinical diagnostics market is expected to grow at a formidable rate during the forecast period. The global clinical diagnostics market is driven by increasing prevalence of diseases caused due to sedentary lifestyle such as diabetes, cardiovascular diseases, high blood pressure, lipid disorders, among others. Furthermore, increase in the number of patients suffering from chronic kidney diseases and cancer is also expected to drive the market for clinical diagnostics during the forecast years. Additionally, benefits such as quick test results, easy procedure of testing, ease of procurement of samples, less pain, among others associated with clinical diagnostics are further anticipated to propel the market through 2025.
The global clinical diagnostics market was valued at around $ 50 billion in 2019. The global clinical diagnostic market can be segmented based on type of test, product, application, end user, company and region. Based on type of test, the market can be fragmented into lipid panel, metabolic panel, infectious disease testing and others. The lipid panel type of test segment is expected to dominate the market during forecast period owing to the significant increase in the number of people suffering from diseases caused due to obesity and sedentary lifestyle. Additionally, growing risks of cardiovascular diseases and cholesterol related problems is further driving the growth of this segment across the globe. Infectious disease segment is expected to exhibit the highest growth due to increase in prevalence of COVID-19. Based on product, the market can be categorized into instruments, reagents, assays and kits, and software. The assays and kits segment is expected to hold a significant market share over the next five years. This can be accredited to the increasing use of assays and kits for COVID-19 testing and in point of care and self-testing product kits.
Among all the regions, North America is expected to dominate the market through 2025. This can be attributed to the increasing health awareness among the population pertaining to the benefits of these tests and flourishing healthcare industry in the region. Asia -Pacific is expected to grow at the highest CAGR due to increasing investments by leading global players as well as and government initiatives.
Major players operating in the global clinical diagnostics market include Abbott Laboratories, bioMerieux, Bio-Rad Laboratories Inc., Danaher Corporation, Becton, Dickinson and Company, Qiagen, Roche Diagnostics, Thermo Fisher Scientific Inc., Sysmex Corporation, among others.
Years considered for this report:
Historical Years: 2015-2018
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2021-2025
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of major diagnostic players and hospital chains operating across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research.
TechSci Research calculated the market size of global clinical diagnostics market using a bottom-up approach, wherein data for various end user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals, diagnostic laboratories and partners, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
In this report, global clinical diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Infectious Disease Testing
Assays and Kits
Middle East & Africa
Company Profiles: Detailed analysis of the major companies present in global clinical diagnostics market.
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: